XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Organization , Description of Business and Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Sep. 30, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Third-party Payers as a Percentage of Total
The Company’s total third-party payers and other customers in excess of 10% of total revenue and their related revenue as a percentage of total revenue were as follows:
 
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Medicare33 %31 %33 %31 %
UnitedHealthcare14 %13 %14 %14 %
 47 %44 %47 %45 %

The Company's significant third-party payers in excess of 10% of total accounts receivable and their related accounts receivable balance as a percentage of total accounts receivable were as follows:
 
 September 30, 2025December 31, 2024
Medicare22 %16 %
UnitedHealthcare12 %12 %
Schedule of Revenue Revenue included in biopharmaceutical and other revenue for the three and nine months ended September 30, 2025 and 2024 was as follows (in thousands of dollars):
 Three Months Ended September 30,Nine Months Ended September 30,
 2025202420252024
Biopharmaceutical revenue$646 $2,041 $5,573 $5,962 
Contract manufacturing and testing169 1,095 3,129 3,730 
Total$815 $3,136 $8,702 $9,692